Molecular Partners AG Sponsored ADR MOLN

4.22 (0.08) (1.86%) as of 25 Sep
Market cap
$160.5M
P/E
0.0×
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Quick Ratio
9.08 8.61 9.21 7.05
Current Ratio
9.28 8.79 9.42 7.27
Net Debt/EBITDA
9.10 7.20 6.09 5.18
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.91 0.72 1.08 0.79
Capex/Depreciation
(0.08) (0.26) 0.00 (0.04)
Interest Coverage
0.00 0.00 0.00 0.00
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Yield
— — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.36) (0.32) (0.48) (0.35)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.36) (0.32) (0.48) (0.35)
Cash per Share
3.51 3.01 2.68 2.22
Shareholders Equity per Share
3.21 2.60 2.33 1.91
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
3.21 2.60 2.33 1.91
Free Cash Flow
(13.59) (11.90) (18.18) (13.53)
Working Capital
121.47 103.62 94.60 77.96
Capital Expenditures
(0.06) (0.14) — (0.03)
Net Current Asset Value
115.38 90.65 81.32 68.68
EV/EBIT
— — — —
Capex to Sales
0.00 0.00 — 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%
Other line items
Average Receivables
3.23 2.42 3.69 3.03
Average Payables
2.70 2.12 2.56 2.31
Average Assets
159.16 151.66 134.41 123.20
Average Common Equity
139.86 128.92 114.98 101.69

Fold the line items

Columns are period end dates